Optimum trephine length in the assessment of bone marrow involvement in patients with diffuse large cell lymphoma

Annals of Oncology

Volumn 14, Issue 2, 2003, Pages 273-276

  Campbell, J K ^a   Matthews, J P ^b   Seymour, J F ^b   Wolf, M M ^c   Juneja, S K ^c  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b PETER MACCALLUM CANCER CENTRE   (Australia)

^c ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Bone marrow involvement; Bone marrow trephine; Diffuse large cell lymphoma

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; EOSIN; ETOPOSIDE; HEMATOXYLIN; PREDNISONE; VINCRISTINE;

ARTICLE; BONE MARROW BIOPSY; BONE MARROW DISEASE; BONE MARROW EXAMINATION; CANCER CENTER; CANCER LOCALIZATION; CANCER PATIENT; CANCER STAGING; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG MEGADOSE; HUMAN; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; MORBIDITY; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; SAMPLING;

EID: 0037294571     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdg055     Document Type: Article

References (21)

1. Shipp MA for the International non-Hodgkin's lymphoma prognostic factors project. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 1993; 329: 987-994.
2. Shipp MA. Prognostic factors in aggressive non-Hodgkin's lymphoma; who has 'high-risk' disease? Blood 1994; 83: 1165-1173.
3. Morra E, Lazzarino M, Castello A et al. Bone marrow and blood involvement by non-Hodgkin's lymphoma: a study of clinicopathologic correlations and prognostic significance in relationship to the Working Formulation. Eur J Haematol 1998; 42: 445-453.
4. Conlan MG, Bast M, Armitage JO, Weinburger DD. Bone marrow involvement by non-Hodgkin's lymphoma: the clinical significance of morphologic discordance between the lymph node and the bone marrow. J Clin Oncol 1990; 8: 1163-1172.
5. Yan Y, Chan WC, Weisenburger DD et al. Clinical and prognostic significance of bone marrow involvement in patients with diffuse large cell lymphoma. J Clin Oncol 1995; 13: 1336-1342.
6. Robertson LE, Redman JR, Butler JJ et al. Discordant bone marrow involvement in diffuse large cell lymphoma: a distinct clinicopathological entity associated with a continuous risk of relapse. J Clin Oncol 1991; 9: 236-242.
7. Hodges GF, Lenhardt TM, Cotelingham JD. Bone marrow involvement in large cell lymphoma. Prognostic implications of discordant disease. Am J Clin Path 1994; 101: 305-311.
8. Cheson BD, Horning SJ, Coiffier B et al. Report of an international workshop to standardise response criteria for non-Hodgkin's lymphomas. J Clin Oncol 1999; 17: 1244-1253.
9. Bain B. Bone marrow trephine biopsy. J Clin Path 2001; 54: 737-742.
10. Bishop PW, McNally K, Harris M. Audit of bone marrow trephines. J Clin Path 1992; 45: 1105-1108.
11. Rosenberg SA, Berard CW, Brown BW et al. National Cancer Institute sponsored study of classification of non-Hodgkin's lymphomas. Summary and description of a working formulation for clinical usage. Cancer 1982; 49: 2112-2135.
12. Cooper IA, Wolf MM, Robertson TI et al. Randomised comparison of MACOP-B with CHOP in patients with intermediate grade non-Hodgkin's lymphoma. J Clin Oncol 1994; 12: 769-778.
13. Wolf M, Matthews JP, Stone J et al. Long term survival advantage of MACOP-B over CHOP in intermediate grade non-Hodgkin's lymphoma. Ann Oncol 1997; 8 (Suppl. 1): 71-75.
14. Wolf M, Matthews J, Stone J et al. Dose-intensification does not improve outcome in aggressive non-Hodgkin's lymphoma (NHL). Report of a randomised trial by the Australasian Leukaemia and Lymphoma Group. American Society of Hematology Annual Meeting, San Francisco, CA, 1-5 December 2000 (Abstr 3593).
15. Juneja SK, Wolf MM, Cooper IA. The value of bilateral bone marrow specimens in non-Hodgkin's lymphoma. J Clin Path 1990; 43: 630-632.
16. Bartl R, Frisch B, Burkhardt R et al. Lymphoproliferations in the bone marrow: identification, evolution, classification and staging. J Clin Path 1984; 37: 233-254.
17. Schmid C, Isaacson PG. Bone marrow trephine biopsy in lymphoproliferative disease. J Clin Path 1992; 45: 745-750.
18. Thiele J, Zirbes TK, Kvasnicka HM, Fischer R. Focal lymphoid aggregates (nodules) in bone marrow biopsies: differentiation between benign hyperplasia and malignant lymphoma-a practical guide. J Clin Path 1999; 52: 294-300.
19. Coller BS, Chabner BA, Gralnick HR. Frequencies and patterns of involvement in non-Hodgkin lymphomas: observations on the value of bilateral biopsies. Am J Hematol 1977; 3: 105-119.
20. Roath S, Choudhury D, Smith A. Bone marrow biopsy in non-Hodgkin's lymphoma. Haematol Rev 1989; 3: 165-176.
21. Nicholaides C, Fountzilas G, Zoumbas N et al. Diffuse large cell lymphomas: identification of prognostic factors and validation of the International non-Hodgkin's lymphoma prognostic index. Oncology 1998; 55: 405-415.